Literature DB >> 30006880

Effect of Water-Soluble Echinochrome Analog on Arrhythmia Severity in Experimental Model of Acute Myocardial Ischemia.

O G Bernikova1,2, K A Sedova3,4, S N Kharin3,5, Ya E Azarov3,5.   

Abstract

The effects of therapeutic or preventive-therapeutic administration of water-soluble echinochrome analog U-441 on arrhythmia severity assessed by a set of myocardial spatio-temporal depolarization and repolarization parameters were examined on the model of acute myocardial ischemia in cats. Coronary occlusion increased activation time and decreased repolarization time in the ischemic zone; in addition, it increased both global and borderline (local) dispersions of repolarization. The linear regression model showed that only activation time values measured at the initial state and at termination of occlusion were associated with total arrhythmia score during ischemia (regression coefficient β=0.338, 95%CI=0.074-0.602, p=0.015 and β=0.720, 95%CI=0.323-1.117, p=0.001, respectively). The study revealed no association between administration of echinochrome analog U-441 and arrhythmia severity.

Entities:  

Keywords:  cats; echinochrome analog U-441; ischemia; predictors; ventricular arrhythmias

Mesh:

Substances:

Year:  2018        PMID: 30006880     DOI: 10.1007/s10517-018-4165-z

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

1.  Association Between Antiarrhythmic, Electrophysiological, and Antioxidative Effects of Melatonin in Ischemia/Reperfusion.

Authors:  Ksenia A Sedova; Olesya G Bernikova; Julia I Cuprova; Alexandra D Ivanova; Galina A Kutaeva; Michael G Pliss; Ekaterina V Lopatina; Marina A Vaykshnorayte; Emiliano R Diez; Jan E Azarov
Journal:  Int J Mol Sci       Date:  2019-12-15       Impact factor: 5.923

Review 2.  Multifaceted Clinical Effects of Echinochrome.

Authors:  Hyoung Kyu Kim; Elena A Vasileva; Natalia P Mishchenko; Sergey A Fedoreyev; Jin Han
Journal:  Mar Drugs       Date:  2021-07-26       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.